These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 26434630)
41. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma. Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661 [TBL] [Abstract][Full Text] [Related]
42. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer. Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805 [TBL] [Abstract][Full Text] [Related]
43. Vimentin expression is associated with decreased survival in gastric cancer. Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330 [TBL] [Abstract][Full Text] [Related]
44. KITENIN is associated with tumor progression in human gastric cancer. Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126 [TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of osteopontin expression in human gastric carcinoma. Higashiyama M; Ito T; Tanaka E; Shimada Y Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150 [TBL] [Abstract][Full Text] [Related]
46. Clinical significance of increased guanine nucleotide exchange factor Vav3 expression in human gastric cancer. Lin KY; Wang LH; Hseu YC; Fang CL; Yang HL; Kumar KJ; Tai C; Uen YH Mol Cancer Res; 2012 Jun; 10(6):750-9. PubMed ID: 22544459 [TBL] [Abstract][Full Text] [Related]
47. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients. Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238 [TBL] [Abstract][Full Text] [Related]
48. Abnormal hypermethylation of promoter region downregulates chemokine CXC ligand 14 expression in gastric cancer. Hu C; Lin F; Zhu G; Xue X; Ding Y; Zhao Z; Zhang L; Shen X Int J Oncol; 2013 Nov; 43(5):1487-94. PubMed ID: 23982764 [TBL] [Abstract][Full Text] [Related]
49. Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation. Ye M; Du YL; Nie YQ; Zhou ZW; Cao J; Li YF Mol Med Rep; 2015 Mar; 11(3):2004-12. PubMed ID: 25395097 [TBL] [Abstract][Full Text] [Related]
50. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma. Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294 [TBL] [Abstract][Full Text] [Related]
51. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159 [TBL] [Abstract][Full Text] [Related]
52. Notch3 and Jagged2 contribute to gastric cancer development and to glandular differentiation associated with MUC2 and MUC5AC expression. Kang H; An HJ; Song JY; Kim TH; Heo JH; Ahn DH; Kim G Histopathology; 2012 Oct; 61(4):576-86. PubMed ID: 22691042 [TBL] [Abstract][Full Text] [Related]
53. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer. Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221 [TBL] [Abstract][Full Text] [Related]
54. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer]. Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802 [TBL] [Abstract][Full Text] [Related]
55. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer. Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362 [TBL] [Abstract][Full Text] [Related]
56. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer. Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328 [TBL] [Abstract][Full Text] [Related]
57. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin. Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387 [TBL] [Abstract][Full Text] [Related]
58. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer. Zhang X; Tsukamoto T; Mizoshita T; Ban H; Suzuki H; Toyoda T; Tatematsu M Oncol Rep; 2009 Mar; 21(3):609-13. PubMed ID: 19212618 [TBL] [Abstract][Full Text] [Related]
59. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679 [TBL] [Abstract][Full Text] [Related]
60. Bmi-1 expression predicts prognosis for patients with gastric carcinoma. Liu JH; Song LB; Zhang X; Guo BH; Feng Y; Li XX; Liao WT; Zeng MS; Huang KH J Surg Oncol; 2008 Mar; 97(3):267-72. PubMed ID: 18041745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]